2005, Número s1
<< Anterior Siguiente >>
Inv Salud 2005; 7 (s1)
Mecanismos moleculares de la regulación transcripcional de colágena α1(I) por las células estelares hepáticas
Hernández NZH, Martínez LE, Domínguez RJA
Idioma: Español
Referencias bibliográficas: 38
Paginas: 33-39
Archivo PDF: 261.68 Kb.
RESUMEN
Las células estelares hepáticas (CEH), se
localizan en el interior del espacio de Disse del
sinusoide hepático. En estado de reposo, producen
las proteínas de tejido conectivo que forman el
estroma hepático y es el principal depósito de
vitamina A. Sin embargo, ante un estímulo nocivo,
sufre un proceso de cambio fenotípico conocido
como activación. Las células activadas se
caracterizan por el incremento de la expresión de la
colágena tipo I, lo que en estado crónico lleva a la
fibrosis o cirrosis del hígado. Actualmente, se sabe
que la activación de estas células depende de un
grupo de citocinas (PDGF-BB, TGF-β1,TNF-α)
producidas por las células de kuppfer o incluso por
las mismas CEH, que a su vez, activan a un grupo de
factores transcripcionales que se unen al promotor
de las colágenas alfa 1(I) y 2(I) y regulan la expresión
del gen.
REFERENCIAS (EN ESTE ARTÍCULO)
Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis, 2001;21:311-335.
No authors. Hepatic Stellate cells [letter]. Hepatology, 1996;23:12.
Geerts A, Bouwens L, Wisse E. Ultrastructure and function of hepatic fat-storing and pit cells. J Electron Microsc Tech, 1990;3:247-256.
Dan L, Friedman SL. Hepatic Stellate cells: morphology, function and regulation. In: IM Arias, JL Boyer, FV Chisari, N Fausto, D Shachter and DA Shafritz, eds. The liver: Biology and Pathobiology, Lipincott Williams & Wilkins Publishers. 2001. 455-468.
Yokoi Y, Namihisa T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S, Usui K. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology, 1984;4:709-714.
Ramadori G, Veit T, Schwogler S, Dienes HP, Knittel T, Rieder H, Meyer zum Buschenfelde KH. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol, 1990;59:349-357.
Niki T, Pekny M, Hellemans K, Bleser PD, Berg KV, Vaeyens F, Quartier E, Schuit F, Geerts A. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology, 1999;29:520-527.
De Leeuw AM, McCarthy SP, Geerts A, Knook DL. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology, 1984;4:392-403.
Buniatian G, Gebhardt R, Schrenk D, Hamprecht B. Colocalization of three types of intermediate filament proteins in perisinusoidal stellate cells: glial fibrillary acidic protein as a new cellular marker. Eur J Cell Biol, 1996;70:23-32.
Cassiman D, Denef C, Desmet VJ, Roskams T. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology, 2001;33:148-158.
Cassiman D, van Pelt J, De Vos R, Van Lommel F, Desmet V, Yap SH, Roskams T. Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol, 1999;155:1831-1839.
Nishi M, Takeshima H, Houtani T, Nakagawara K, Noda T, Sugimoto T. RhoN, a novel small GTP-binding protein expressed predominantly in neurons and hepatic stellate cells. Mol Brain Res, 1999;67:74-81.
Zou Z, Ekataksin W, Wake K. Zonal and regional differences identified from precision mapping of vitamin A-storing lipid droplets of the hepatic stellate cells in pig liver: a novel concept of addressing the intralobular area of heterogeneity. Hepatology, 1998;27:1098-10108.
Rojkind M, Greenwel P. Pathophysiology of liver fibrosis In: IM Arias, JL Boyer, FV Chisari, N Fausto, D Shachter and DA Shafritz, eds. The liver: Biology and Pathobiology, Lipincott Williams & Wilkins Publishers. 2001. 721-738.
Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res, 1999;23:911-916.
Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver, 1998;18:2-13.
Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 2000;279:G245-249.
Saile B, Matthes N, Knittel T, Ramadori G. Transforming growth factor and tumor necrosis factor inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology, 1999;30:196-202.
Rojkind M. Role of metalloproteinases in liver fibrosis. Alcohol Clin Exp Res, 1999;23:934-939.
Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology, 1979;76:710-719.
Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res, 1999;41:376-384.
Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Integrating cells into tissues. In: Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. eds. Molecular Cell Biology. W.H. Freeman and company publishers, New York, USA. 2000. 968-1002.
Vuorio E, de Crombrugghe B. The family of collagen genes. Annu Rev Biochem, 1990;59:837-872.
Ghosh AK. Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood), 2002;227:301-314.
Gabele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci, 2003;8:D69-77.
Brenner DA, Rippe RA, Rhodes K, Trotter JF, Breindl M. Fibrogenesis and type I collagen gene regulation. J Lab Clin Med, 1994;124:755-760.
Jimenez SA, Saitta B. Alterations in the regulation of expression of the alpha 1 (I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Semin Immunopathol, 1999;21:397-414.
Saitta B, Gaidarova S, Cicchillitti L, Jimenez SA. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum, 2000;43:2219-2229.
Rippe RA, Almounajed G, Brenner DA. Sp1 binding activity increases in activated Ito cells. Hepatology, 1995;22:241-251.
Hernandez I, de la Torre P, Rey-Campos J, Garcia I, Sanchez JA, Munoz R, Rippe RA, Munoz-Yague T, Solis-Herruzo JA. Collagen alpha 1 (I) gene contains an element responsive to tumor necrosis factor-alpha located in the 5' untranslated region of its first exon. DNA Cell Biol, 2000;19:341-352.
Bornstein P. Regulation of expression of the alpha 1 (I) collagen gene: a critical appraisal of the role of the first intron. Matrix Biol, 1996;15:3-10.
Armendariz-Borunda J, Simkevich CP, Roy N, Raghow R, Kang AH, Seyer JM. Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression. Biochem J, 1994;304(Pt 3):817-824.
Rippe RA, Schrum LW, Stefanovic B, Solis-Herruzo JA, Brenner DA. NF-kappaB inhibits expression of the alpha 1 (I) collagen gene. DNA Cell Biol, 1999;18:751-761.
Wedel A, Ziegler-Heitbrock HW. The C/EBP family of transcription factors. Immunobiology, 1995;193:171-185.
Timchenko NA, Welm AL, Lu X, Timchenko LT. CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res, 1999;27:4517-4525.
Houglum K, Buck M, Adir V, Chojkier M. LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5’ regulatory region. J Clin Invest, 1994;94:808-814.
Attard FA, Wang L, Potter JJ, Rennie-Tankersley L, Mezey E. CCAAT/ enhancer binding protein b mediates the activation of the murine a1(I) collagen promoter by acetaldehyde. Arch Biochem Biophphys, 2000;378:57-64.
Garcia-Trevijano ER, Iraburu MJ, Fontana L, Dominguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M. Transforming growth factor beta1 induces the expression of alpha 1 (I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology, 1999;29:960-970.